About Us LMPG Guidelines NACB Home Page
Top Nav Bar
Nav Bar
About NACB
Board of Directors

Membership Services
LMPG Guidelines
Meetings and Conferences
NACB Newsletter
Historical Archive

National Academy of Clinical Biochemistry Distinguished Abstract Awards

The NACB is proud to announce the following recipients of its 2005 Distinguished Abstract Awards. This Academy program is designed to promote the scholarship of discovery and recognize scientific excellence among abstracts accepted for presentation at the AACC Annual Meeting. The following 25 abstracts were chosen from 837 abstracts accepted for presentation at the 2005 AACC Annual Meeting.

A rigorous selection process is used that incorporates a primary review by AACC members followed by a second review performed by a group of NACB Fellows. Only those abstracts that meet strict criteria during both reviews are designated as Distinguished Abstracts.

Tuesday, July 26, 10:00 a.m. A-108
Anissa Djemli, PhD
Cystatin C: A Marker of Kidney Function in Pediatric Oncology.

Tuesday, July 26, 10:00 a.m. A-140
David W. Seccombe, MD, PhD
Standardization of Creatinine: a Pre-requisite for Implementing the MDRD Formula for the Estimation of Glomerular Filtration Rate (eGFR)

Tuesday, July 26, 10:00 a.m. A-145
Raffick A. Bowen, PhD
Investigation of Immunoassay Interference from Reformulated Blood Collection Tubes.

Tuesday, July 26, 2:00 p.m. B-13
Maninder Kaur
Diagnostic and Prognostic Value of Serum Glycoproteins (Sialic Acid and Hexosamines) in Breast Cancer.

Tuesday, July 26, 2:00 p.m. B-19
Bernard C. Cook, PhD
The Use of the Prostate Specific Antigen (PSA) Isoforms, BPH-A and ProPSA, to Improve the Specificity of PSA Tests for Cancer and Benign Prostatic Hyperplasia.

Tuesday, July 26, 2:00 p.m. B-34
Ross J. Molinaro
Identification of RNA Activators of 2’,5’-Oligoadenylate Synthetase in Prostate Cancer Cells

Tuesday, July 26, 2:00 p.m. B-85
Dan Chen, PhD
The Correlation of Hepatitis B(HB) viral DNA in HBsAg Weakly Positive Samples by the Immulite 2000 Assay

Tuesday, July 26, 2:00 p.m. B-123
Gausai A. Khan
Isolation and Characterization of a Novel Protein from Goat Kidney and its Involvement in Nitric Oxide Production

Tuesday, July 26, 2:00 p.m. B-131
Michael N. Fahie-Wilson
Macro Creatine Kinase (MacroCK): Should We Be Screening for It?

Wednesday, July 27, 10:00 a.m. C-7
Mohamed Allam, MD, PhD
The Hypotensive Effect of Isoflurane Might be Related to Increased Production of Nitric Oxide

Wednesday, July 27, 10:00 a.m. C-8
Mohamed Allam, MD, PhD
Up Regulation of Angiogenic Growth Factors is Associated with Renal Dysfunction in Type 2 Diabetes Mellitus

Wednesday, July 27, 10:00 a.m. C-9
Mohamed Allam, MD, PhD
Impact of Renal Functional Impairment on Serum Tumor Markers Levels

Wednesday, July 27, 10:00 a.m. C-30
Mustafa Serteser
Carbohydrate-Deficient Transferrin Levels in Non-Alcoholic Psychiatric Patients: Could It Be Used to Discriminate Psychiatric Disorders?

Wednesday, July 27, 10:00 a.m. C-56
Peter I. Kupchak, PhD
Clinical Utility of Highly Sensitive Assays for Biochemical Markers of Traumatic Brain Injury in the Emergency Department: A Prospective Case-Control Study

Wednesday, July 27, 10:00 a.m. C-60
Christa M. Cobbaert, PhD
Significance of HFE (C282Y, H63D) and FPNI (N144H) Gene Mutations in the Development of Cardiovascular Disease. Results from the Dutch Prospective Monitoring Project on Cardiovascular Disease Risk Factors.

Wednesday, July 27, 10:00 a.m. C-66
Anthony P. Furnary
The Portland Diabetic Project: Correcting the Unfair Disadvantage for Diabetic Patients Undergoing Cardiac Surgery

Wednesday, July 27, 10:00 a.m. C-87
Scott J. Cameron, PhD
A Novel Atheroprotective Mechanism for High Density Lipoprotein: Attenuation of Endothelial Cell Inflammation.

Wednesday, July 28, 10:00 a.m. C-143
Douglas F. Stickle, PhD
Evaluation of Effects of Varying Hematocrit on Injected Mass of Internal Standard in Immunosuppressants Measurement by Tandem Mass Spectrometry

Wednesday, July 27, 10:00 a.m. C-150
Alejandro R. Molinelli
Increased Hydrogen Peroxide-Induced DNA Strand Breaks by Arsenic Compounds in Human Cells

Wednesday, July 27, 10:00 a.m. C-158
Marjorie Bon Homme
Potential Role for IFN-? and IL-6 in Mediating Adaptive Tolerance to Acute Acetaminophen Toxicity

Wednesday, July 27, 2:00 p.m. D-87
Dr. Christian Götting
Detection of Novel ABCC6 Sequence Variations in Pseudoxanthoma Elasticum Patients from German Descent

Wednesday, July 27, 2:00 p.m. D-125
Dean W. Joelson
Rarity of Folate Deficiency Suggests Limited Clinical Utility of Routine Folate Testing

Thursday, July 28, 10:00 a.m. E-31
Leslie Holland
The Role of Automation in Reducing Test Turnaround Time Outliers and Decreasing Patient Length of Stay in the Emergency Department

Thursday, July 29, 10:00 a.m. E-125
Hassan M. Hussien Qazzaz, PhD
Evidence that DLIF and OLF have Different Biosynthetic Pathways in Adrenal Cells: A Potential New Model for Steroidogenesis in Adrenal Cells

Thursday, July 28, 10:00 a.m. E-144
Mark D. Shephard
Point-of-Care HbA1c and Urine ACR Testing for Diabetes Management in Rural and Remote Australian Aboriginal Medical Services - the 'QAAMS' Program Sets an International Precedent